grant

Crosstalk of Immune Dysregulation and Impaired Wound Healing in inherited STAT4-mediated Autoinflammatory Disease

Organization UNIVERSITY OF CALIFORNIA, SAN DIEGOLocation LA JOLLA, UNITED STATESPosted 1 Feb 2025Deadline 31 Jan 2030
NIHUS FederalResearch GrantFY2025AcLDLAffectAngiogenesis FactorAngiogenic FactorAssayAttentionB cell differentiation factorB cell stimulating factor 2B-Cell Differentiation FactorB-Cell Differentiation Factor-2B-Cell Stimulatory Factor-2BCDFBSF-2BSF2BioassayBiological AssayBleedingBlood VesselsBone MarrowBone Marrow Blood-Deriving CellBone Marrow Blood-Forming CellBone Marrow CellsBone Marrow Reticuloendothelial SystemCancersCell BodyCell Communication and SignalingCell FunctionCell PhysiologyCell ProcessCell SignalingCellsCellular FunctionCellular PhysiologyCellular ProcessCessation of lifeChemotactic CytokinesChildhoodChronicCompetenceCritical PathsCritical PathwaysCytoplasmCytotoxic cellDNA mutationDataDeathDeath RateDefectDevelopmentDiagnosisDisablingDiseaseDisease ProgressionDisorderEndothelial CellsExperimental ModelsFITC-dextranFailureFamilyFibroblastsGene TranscriptionGene variantGeneticGenetic ChangeGenetic PredispositionGenetic Predisposition to DiseaseGenetic SusceptibilityGenetic TranscriptionGenetic defectGenetic mutationGenetic propensityGenetic studyHPGFHematopoieticHemorrhageHepatocyte-Stimulating FactorHereditaryHomeHomologous Chemotactic CytokinesHumanHybridoma Growth FactorIFN-beta 2IFNB2IL-6IL6 ProteinImmuneImmunesImmunomodulationImpaired tissue repairImpaired wound healingIn VitroInflammationInflammatoryInheritedInherited PredispositionInherited SusceptibilityIntercrinesInterleukin-6Intracellular Communication and SignalingInvestigationInvestigatorsJointsJournalsK lymphocyteKnock-inLeadLifeLymphatic cellLymphocyteLymphocyticMGI-2MagazineMalignant NeoplasmsMalignant TumorMediatingMedicalMedicineMembraneMendelian diseaseMendelian disorderMendelian genetic disorderMiceMice MammalsModelingModern ManMolecularMorbidityMorbidity - disease rateMorpheaMucosaMucosal TissueMucous MembraneMurineMusMutationMyeloid Differentiation-Inducing ProteinNK CellsNatural Killer CellsNatureNew EnglandNon-Polyadenylated RNANortheastern United StatesOxidative StressOxidative Stress InductionPancytopeniaPathologicPathologyPathway interactionsPatientsPb elementPeripheralPermeabilityPhenotypePhosphorylationPlasmacytoma Growth FactorPrimary ImmunodeficiencyProductionProgenitor CellsProtein PhosphorylationProteomicsRNARNA ExpressionRNA Gene ProductsRNA SeqRNA sequencingRNAseqResearch PersonnelResearchersRibonucleic AcidRoleSIS cytokinesSTAT4STAT4 geneSignal PathwaySignal TransductionSignal Transduction SystemsSignalingSkinSubcellular ProcessSymptomsSyndromeT-Cell DevelopmentT-Cell OntogenyT-Lymphocyte DevelopmentTestingTranscriptionUpregulationVariantVariationWound Repairabnormal tissue repairacetyl-LDLacetyl-low density lipoproteinsacetylated LDLacetylated low density lipoproteinallelic variantangiogenesisautoinflammationautoinflammatoryautoinflammatory diseasesautoinflammatory disordersautosomebiological signal transductionblood losschemoattractant cytokinechemokinecongenital immune deficiencycongenital immunodeficiencycutaneous fibrosiscytokinecytopeniadelayed wound healingdermal fibrosisdevelopmentalexhaustionfibrotic skinfluorescein isothiocyanate dextranfluoresceinthiocarbamoyl dextransgain of functiongain of function mutationgenetic etiologygenetic immune defectgenetic immune deficiencygenetic immunodeficiencygenetic mechanism of diseasegenetic variantgenetic vulnerabilitygenetically predisposedgenome mutationgenomic variantheavy metal Pbheavy metal leadhemopoietichomeshypogammaglobulinemiaiPSiPSCiPSCsimmune modulationimmune regulationimmunologic reactivity controlimmunomodulatoryimmunoregulationimmunoregulatoryimprovedin vivoinborn errors in immunityinborn errors of immunityinborn immunodeficiencyinduced pluripotent cellinduced pluripotent stem cellinduced pluripotent stem cells derived from patientsinduced pluripotent stem cells from patientsinducible pluripotent cellinducible pluripotent stem cellineffective therapiesineffective treatmentinfection recurrenceinherited immune defectinherited immune deficiencyinherited immunodeficiencyinhibitorinterferon beta 2knockinlymph cellmalignancymembrane structuremonogenic diseasemonogenic disordermortalitymortality ratemortality rationeoplasm/cancerneovascularizationnew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnovelnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapypathwaypatient derived human iPSpatient derived human iPSCpatient derived human induced pluripotent stem cellpatient derived iPSpatient derived iPSCpatient derived induced pluripotent cellspatient derived induced pluripotent stem cellspatient-derived pluripotent stem cellspediatricpharmacologicpreventpreventingprimary immune defectprimary immune deficiencyprogenitorrecurrent infectionrecurring infectionsingle-gene diseasesingle-gene disorderskin fibrosissocial rolestem cellssystemic inflammationsystemic inflammatory responsetherapeutic targettissue woundtranscriptome sequencingtranscriptomic sequencingtranscriptomicsuptakevascularwoundwound healingwound recoverywound resolutionwoundingwounds
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Abstract
Disabling pansclerotic morphea (DPM) is a severe, systemic disorder of childhood with debilitating skin, joint,

and mucosal symptoms, immune dysregulation and malignancy. DPM is known to be severely recalcitrant to

therapy, leading to death within 10 years of diagnosis. Our investigation of the specific contribution of STAT4 to

the…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →